|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023981,
umls-concept:C0025266,
umls-concept:C0040223,
umls-concept:C0220908,
umls-concept:C0376358,
umls-concept:C0599755,
umls-concept:C0681842,
umls-concept:C0682075,
umls-concept:C0920688,
umls-concept:C1280500,
umls-concept:C1336641
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-1-26
|
|
pubmed:abstractText |
To evaluate the TMPRSS2-ERG gene polymorphism with respect to self-identified race or ethnicity (SIRE), time to prostate cancer (PCA) diagnosis, and screening parameters in the Prostate Cancer Risk Assessment Program, a prospective screening program for high-risk men.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
466-70
|
|
pubmed:dateRevised |
2011-9-26
|
|
pubmed:meshHeading |
pubmed-meshheading:20735386-Adult,
pubmed-meshheading:20735386-Aged,
pubmed-meshheading:20735386-Biopsy,
pubmed-meshheading:20735386-Early Detection of Cancer,
pubmed-meshheading:20735386-Epidemiologic Methods,
pubmed-meshheading:20735386-Ethnic Groups,
pubmed-meshheading:20735386-Gene Frequency,
pubmed-meshheading:20735386-Genetic Testing,
pubmed-meshheading:20735386-Humans,
pubmed-meshheading:20735386-In Situ Hybridization, Fluorescence,
pubmed-meshheading:20735386-Male,
pubmed-meshheading:20735386-Mass Screening,
pubmed-meshheading:20735386-Middle Aged,
pubmed-meshheading:20735386-Oncogene Proteins, Fusion,
pubmed-meshheading:20735386-Polymorphism, Genetic,
pubmed-meshheading:20735386-Prostate,
pubmed-meshheading:20735386-Prostate-Specific Antigen,
pubmed-meshheading:20735386-Prostatic Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.
|
|
pubmed:affiliation |
Cancer Prevention and Control Program, Department of Clinical Genetics, Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Veda.Giri@fccc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
